SD Biosensor, Inc. (KRX:137310)
South Korea · Delayed Price · Currency is KRW 8,200.00
+310.00 (3.93%)
At close: Apr 10, 2026
SD Biosensor Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -512,106 | -98,411 | -467,712 | 911,362 | 1,088,471 |
Depreciation & Amortization | 134,266 | 141,694 | 137,541 | 40,820 | 19,115 |
Loss (Gain) From Sale of Assets | -7,748 | -4,092 | 1,045 | 1,804 | 1,373 |
Asset Writedown & Restructuring Costs | 753,790 | 135,262 | 99,869 | 8,634 | 2,283 |
Loss (Gain) From Sale of Investments | -530.94 | 12,378 | -4,046 | -3,107 | -9,480 |
Loss (Gain) on Equity Investments | 15,155 | 3,532 | 986.91 | 2,560 | -2,802 |
Stock-Based Compensation | 803.15 | 905.39 | 969.1 | 15,559 | 18,867 |
Provision & Write-off of Bad Debts | -923.75 | 6,976 | 4,057 | 9,640 | 1,319 |
Other Operating Activities | 22,884 | -24,055 | -33,212 | -31,661 | 224,801 |
Change in Accounts Receivable | -29,370 | 9,636 | -5,177 | 62,516 | 185,970 |
Change in Inventory | -10,303 | -5,896 | 81,644 | -28,604 | 35,418 |
Change in Accounts Payable | 19,635 | 8,069 | -31,006 | -36,683 | -304,205 |
Change in Other Net Operating Assets | -28,037 | -29,472 | -27,277 | -63,831 | -26,185 |
Operating Cash Flow | 357,516 | 156,527 | -242,319 | 889,008 | 1,234,945 |
Operating Cash Flow Growth | 128.41% | - | - | -28.01% | 149.29% |
Capital Expenditures | -57,086 | -78,783 | -142,566 | -301,999 | -190,053 |
Sale of Property, Plant & Equipment | 86,381 | 9,568 | 2,962 | 2,915 | 731.12 |
Cash Acquisitions | -8,066 | - | -1,748,595 | -47,154 | -36,764 |
Divestitures | - | 565.25 | - | - | - |
Sale (Purchase) of Intangibles | -403.73 | -2,118 | -1,864 | -3,248 | -1,980 |
Investment in Securities | -155,268 | -260,670 | -16,366 | 706,574 | -901,853 |
Other Investing Activities | 860.71 | -7,649 | -6,100 | 2,658 | 169,690 |
Investing Cash Flow | -139,944 | -338,926 | -1,912,529 | 359,745 | -960,569 |
Short-Term Debt Issued | 3,059 | - | - | 81,679 | - |
Long-Term Debt Issued | 14,933 | 13,640 | 835,483 | - | - |
Total Debt Issued | 17,993 | 13,640 | 835,483 | 81,679 | - |
Short-Term Debt Repaid | -1,940 | -133,468 | -255,617 | -81,695 | -1,765 |
Long-Term Debt Repaid | -8,042 | -8,041 | -13,822 | -11,623 | -4,968 |
Total Debt Repaid | -9,982 | -141,509 | -269,439 | -93,319 | -6,733 |
Net Debt Issued (Repaid) | 8,011 | -127,869 | 566,044 | -11,640 | -6,733 |
Issuance of Common Stock | 164.82 | - | 227,604 | 2,383 | 507,472 |
Repurchase of Common Stock | -11,575 | -18,425 | - | - | -99,644 |
Dividends Paid | -24,183 | -38.07 | -29,550 | -198,735 | -49,831 |
Other Financing Activities | 0 | 67.3 | 5,664 | -17,745 | 2,839 |
Financing Cash Flow | -27,582 | -146,266 | 769,762 | -225,737 | 354,102 |
Foreign Exchange Rate Adjustments | -633.56 | 23,705 | -5,476 | -31,665 | 9,899 |
Net Cash Flow | 189,356 | -304,960 | -1,390,561 | 991,351 | 638,377 |
Free Cash Flow | 300,431 | 77,744 | -384,884 | 587,008 | 1,044,892 |
Free Cash Flow Growth | 286.44% | - | - | -43.82% | 137.22% |
Free Cash Flow Margin | 42.28% | 11.19% | -58.70% | 20.02% | 35.66% |
Free Cash Flow Per Share | 2510.30 | 635.94 | -3471.82 | 5794.81 | 10714.52 |
Cash Interest Paid | 25,684 | 31,855 | 59,592 | 984.72 | 497.84 |
Cash Income Tax Paid | -338,038 | -84,493 | 198,926 | 537,064 | 132,849 |
Levered Free Cash Flow | -44,627 | -93,587 | -250,134 | 402,401 | 766,104 |
Unlevered Free Cash Flow | 23,014 | -50,719 | -219,366 | 403,022 | 766,410 |
Change in Working Capital | -48,074 | -17,662 | 18,183 | -66,603 | -109,001 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.